Shimizu, T.; Miyake, M.; Nishimura, N.; Yoshida, T.; Itami, Y.; Tachibana, A.; Omori, C.; Oda, Y.; Kohashi, M.; Tomizawa, M.;
et al. Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. Cancers 2024, 16, 841.
https://doi.org/10.3390/cancers16040841
AMA Style
Shimizu T, Miyake M, Nishimura N, Yoshida T, Itami Y, Tachibana A, Omori C, Oda Y, Kohashi M, Tomizawa M,
et al. Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. Cancers. 2024; 16(4):841.
https://doi.org/10.3390/cancers16040841
Chicago/Turabian Style
Shimizu, Takuto, Makito Miyake, Nobutaka Nishimura, Takanori Yoshida, Yoshitaka Itami, Akira Tachibana, Chihiro Omori, Yuki Oda, Mikiko Kohashi, Mitsuru Tomizawa,
and et al. 2024. "Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors" Cancers 16, no. 4: 841.
https://doi.org/10.3390/cancers16040841
APA Style
Shimizu, T., Miyake, M., Nishimura, N., Yoshida, T., Itami, Y., Tachibana, A., Omori, C., Oda, Y., Kohashi, M., Tomizawa, M., Onishi, K., Hori, S., Morizawa, Y., Dotoh, D., Nakai, Y., Torimoto, K., Tanaka, N., & Fujimoto, K.
(2024). Impact of Complete Surgical Resection of Metastatic Lesions in Patients with Advanced Renal Cell Carcinoma in the Era of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors. Cancers, 16(4), 841.
https://doi.org/10.3390/cancers16040841
